These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 36120867

  • 1. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G, Wu L, Zheng Q, Jiang X.
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH, Arslan N, Esen N, Özkütük AA.
    Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
    [Abstract] [Full Text] [Related]

  • 3. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J, Wang F, Hong CY, Li JL, Liang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [Abstract] [Full Text] [Related]

  • 4. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A.
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [Abstract] [Full Text] [Related]

  • 5. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
    Fröberg G, Maurer FP, Chryssanthou E, Fernström L, Benmansour H, Boarbi S, Mengshoel AT, Keller PM, Viveiros M, Machado D, Fitzgibbon MM, Mok S, Werngren J, Cirillo DM, Alcaide F, Hyyryläinen HL, Aubry A, Andres S, Nadarajan D, Svensson E, Turnidge J, Giske CG, Kahlmeter G, Cambau E, van Ingen J, Schön T, EUCAST AMST and ESCMYC study groups.
    Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087
    [Abstract] [Full Text] [Related]

  • 6. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V, Makarova M, Galkina K, Khachaturiants E, Krasnova M, Guntupova L, Safonova S.
    PLoS One; 2018 Jun; 13(9):e0203108. PubMed ID: 30222736
    [Abstract] [Full Text] [Related]

  • 7. Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study.
    Ruedas-López A, Tato M, Broncano-Lavado A, Esteban J, Ruiz-Serrano MJ, Sánchez-Cueto M, Toro C, Domingo D, Cacho J, Barrado L, López-Roa P.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0504122. PubMed ID: 37212700
    [Abstract] [Full Text] [Related]

  • 8. In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria.
    Brown-Elliott BA, Rubio A, Wallace RJ.
    Antimicrob Agents Chemother; 2018 Nov 15; 62(11):. PubMed ID: 30126964
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022.
    Wang DM, Liu H, Zheng YL, Xu YH, Liao Y.
    Front Cell Infect Microbiol; 2023 Nov 15; 13():1282902. PubMed ID: 38029240
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
    Hershko Y, Adler A.
    Microb Drug Resist; 2023 Jul 15; 29(7):302-308. PubMed ID: 37219996
    [Abstract] [Full Text] [Related]

  • 11. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K, Uesugi F, Furuuchi K, Tanaka Y, Yoshiyama T, Saotome M, Ohta K, Mitarai S, Morimoto K.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0192821. PubMed ID: 34878300
    [Abstract] [Full Text] [Related]

  • 12. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Wanger A, Boulet B, Plaunt M, Brown BA, Wallace RJ.
    J Clin Microbiol; 1999 Jun 22; 37(6):1676-82. PubMed ID: 10325306
    [Abstract] [Full Text] [Related]

  • 13. Cumulative antimicrobial susceptibilities for respiratory clinical isolates of Mycobacterium avium Complex, Mycobacterium kansasii, and Mycobacterium abscessus from Pakistan 2018 to 2022.
    Shakoor S, Shafiq S, Shahid A, Mir F, Ali R, Hasan R.
    Int J Mycobacteriol; 2023 Jun 22; 12(3):310-315. PubMed ID: 37721238
    [Abstract] [Full Text] [Related]

  • 14. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
    Sharma M, Malhotra B, Khandelwal S.
    Indian J Med Microbiol; 2021 Jul 22; 39(3):306-310. PubMed ID: 33846029
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
    Lee MC, Sun PL, Wu TL, Wang LH, Yang CH, Chung WH, Kuo AJ, Liu TP, Lu JJ, Chiu CH, Lai HC, Chen NY, Yang JH, Wu TS.
    J Antimicrob Chemother; 2017 Oct 01; 72(10):2782-2786. PubMed ID: 29091186
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G, Pang H, Guo Q, Huang M, Tan Y, Li C, Wei J, Xia Y, Jiang Y, Zhao X, Liu H, Zhao LL, Liu Z, Xu D, Wan K.
    Int J Antimicrob Agents; 2017 Mar 01; 49(3):364-374. PubMed ID: 28131606
    [Abstract] [Full Text] [Related]

  • 17. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.
    J Infect Chemother; 2018 Apr 01; 24(4):315-318. PubMed ID: 29223615
    [Abstract] [Full Text] [Related]

  • 18. In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics.
    Shen Y, Wang X, Jin J, Wu J, Zhang X, Chen J, Zhang W.
    Biomed Res Int; 2018 Apr 01; 2018():4902941. PubMed ID: 30687747
    [Abstract] [Full Text] [Related]

  • 19. In Vitro Susceptibility Testing of Eravacycline against Nontuberculous Mycobacteria.
    Brown-Elliott BA, Wallace RJ.
    Antimicrob Agents Chemother; 2022 Sep 20; 66(9):e0068922. PubMed ID: 35943269
    [Abstract] [Full Text] [Related]

  • 20. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY.
    J Clin Microbiol; 2019 Aug 20; 57(8):. PubMed ID: 31167842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.